AU2002224046A1 - Nootropic effect enhancer - Google Patents
Nootropic effect enhancerInfo
- Publication number
- AU2002224046A1 AU2002224046A1 AU2002224046A AU2404602A AU2002224046A1 AU 2002224046 A1 AU2002224046 A1 AU 2002224046A1 AU 2002224046 A AU2002224046 A AU 2002224046A AU 2404602 A AU2404602 A AU 2404602A AU 2002224046 A1 AU2002224046 A1 AU 2002224046A1
- Authority
- AU
- Australia
- Prior art keywords
- effect enhancer
- nootropic effect
- nootropic
- enhancer
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/28—Nitrogen atoms
- C07D295/32—Nitrogen atoms acylated with carboxylic or carbonic acids, or their nitrogen or sulfur analogues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000-373260 | 2000-12-07 | ||
JP2000373260 | 2000-12-07 | ||
PCT/JP2001/010068 WO2002045715A1 (en) | 2000-12-07 | 2001-11-16 | Nootropic effect enhancer |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002224046A1 true AU2002224046A1 (en) | 2002-06-18 |
Family
ID=18842674
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002224046A Abandoned AU2002224046A1 (en) | 2000-12-07 | 2001-11-16 | Nootropic effect enhancer |
Country Status (6)
Country | Link |
---|---|
US (2) | US20040029894A1 (en) |
EP (1) | EP1340499A4 (en) |
JP (1) | JPWO2002045715A1 (en) |
AU (1) | AU2002224046A1 (en) |
CA (1) | CA2431181A1 (en) |
WO (1) | WO2002045715A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002045715A1 (en) * | 2000-12-07 | 2002-06-13 | Fujisawa Pharmaceutical Co., Ltd. | Nootropic effect enhancer |
JPWO2003047625A1 (en) * | 2001-12-07 | 2005-04-14 | 知之 西崎 | Neurotransmitter |
KR101517414B1 (en) * | 2014-04-24 | 2015-05-04 | 고려대학교 산학협력단 | A composition for prevention and treatment of inflammatory diseases |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI95572C (en) * | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Process for the preparation of a medicament useful as a piperidine derivative or its pharmaceutical salt |
GB8917687D0 (en) * | 1989-08-02 | 1989-09-20 | Fujisawa Pharmaceutical Co | Aminopiperazine derivatives,processes for preparation thereof and pharmaceutical composition comprising the same |
US5250528A (en) * | 1989-08-02 | 1993-10-05 | Fujisawa Pharmaceutical Co., Ltd. | New aminopiperazine derivatives |
PT704439E (en) * | 1993-06-18 | 2001-12-28 | Fujisawa Pharmaceutical Co | A NEW INTERMEDIARY FOR SYNTHETIC USE AND PROCESS FOR THE PREPARATION OF AMINOPIPERAZINE DERIVATIVES |
AT403803B (en) * | 1996-04-19 | 1998-05-25 | Sanochemia Ltd | NEW BENZAZEPINE DERIVATIVES, THESE MEDICINAL PRODUCTS AND THE USE THEREOF FOR THE PRODUCTION OF MEDICINAL PRODUCTS |
ZA9710872B (en) * | 1996-12-12 | 1998-06-15 | Fujisawa Pharmaceutical Co | N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate. |
KR20000057303A (en) * | 1996-12-24 | 2000-09-15 | 후지야마 아키라 | New use of aminopiperazine derivatives |
CA2304682A1 (en) * | 1997-10-09 | 1999-04-22 | Fujisawa Pharmaceutical Co., Ltd. | New process for producing aminopiperazine derivatives |
AUPP818099A0 (en) * | 1999-01-14 | 1999-02-11 | Fujisawa Pharmaceutical Co., Ltd. | New n-containing heterocyclic compounds |
US6344358B1 (en) * | 1999-05-28 | 2002-02-05 | Fujisawa Pharmaceutical Co., Ltd. | Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property |
GB0021885D0 (en) * | 2000-09-06 | 2000-10-18 | Fujisawa Pharmaceutical Co | New use |
WO2002045715A1 (en) * | 2000-12-07 | 2002-06-13 | Fujisawa Pharmaceutical Co., Ltd. | Nootropic effect enhancer |
JP2003063992A (en) * | 2001-08-28 | 2003-03-05 | Fujisawa Pharmaceut Co Ltd | AGENT FOR SPECIFICALLY INCREASING ELECTRIC CURRENT IN N- TYPE Ca2+ CHANNEL |
-
2001
- 2001-11-16 WO PCT/JP2001/010068 patent/WO2002045715A1/en active Application Filing
- 2001-11-16 EP EP01999372A patent/EP1340499A4/en not_active Withdrawn
- 2001-11-16 AU AU2002224046A patent/AU2002224046A1/en not_active Abandoned
- 2001-11-16 CA CA002431181A patent/CA2431181A1/en not_active Abandoned
- 2001-11-16 US US10/433,569 patent/US20040029894A1/en active Pending
- 2001-11-16 JP JP2002547499A patent/JPWO2002045715A1/en active Pending
-
2005
- 2005-11-23 US US11/285,199 patent/US20060074091A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20040029894A1 (en) | 2004-02-12 |
EP1340499A1 (en) | 2003-09-03 |
EP1340499A4 (en) | 2006-05-03 |
CA2431181A1 (en) | 2002-06-13 |
US20060074091A1 (en) | 2006-04-06 |
WO2002045715A1 (en) | 2002-06-13 |
JPWO2002045715A1 (en) | 2004-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6419701A (en) | Electropancreatography | |
AU2001262847A1 (en) | Language-understanding | |
AU2001234470A1 (en) | Cardiac-cell specific enhancer elements and uses thereof | |
AU2001292739A1 (en) | 1-oxorapamycins | |
AU2001254546A1 (en) | Aminopiperidines | |
AU2001220246A1 (en) | Neckphone | |
AU2001265089A1 (en) | Rc-timer scheme | |
AU2002211620A1 (en) | Autoanastomosis | |
AU2001258349A1 (en) | Bisacylguanidine | |
AU2001296577A1 (en) | Chlorophyllases | |
AU2001252971A1 (en) | Tiller | |
AU2001279754A1 (en) | Indoloquinazolinones | |
AU2001285886A1 (en) | 2-guanidino-4-aryl-quinazoline | |
AU2001290931A1 (en) | Ski-snowboard | |
AU2001265871A1 (en) | Substituted sulfonylaminopyrimidines | |
AU2001258924A1 (en) | Microsatellite-aflp | |
AU2001293852A1 (en) | Sulfonylguanidine | |
AU2001254731A1 (en) | Substituted phenyluracils | |
AU2001258255A1 (en) | Substituted benzoylcyclohexenones | |
AU2002226346A1 (en) | 2-aryl-5-trifluoromethylpyridines | |
AU2001281921A1 (en) | Bdellosomes | |
AU2001291876A1 (en) | Triazolo-epothilones | |
AU2001246864A1 (en) | Hypotensors | |
AU2002214354A1 (en) | Neck-phone | |
AU2002224046A1 (en) | Nootropic effect enhancer |